Patents by Inventor Brian L. Burback

Brian L. Burback has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12285416
    Abstract: Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.
    Type: Grant
    Filed: June 21, 2022
    Date of Patent: April 29, 2025
    Assignee: Battelle Memorial Institute
    Inventors: Brian L. Burback, Jessica Catherine Bright, Jerry D. Johnson
  • Publication number: 20230054382
    Abstract: Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.
    Type: Application
    Filed: June 21, 2022
    Publication date: February 23, 2023
    Inventors: Brian L. Burback, Jessica Catherine Bright, Jerry D. Johnson
  • Patent number: 11382906
    Abstract: Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: July 12, 2022
    Assignees: Battelle Memorial Institute
    Inventors: Brian L. Burback, Jessica Catherine Bright, Jerry D. Johnson
  • Patent number: 10702510
    Abstract: Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: July 7, 2020
    Assignee: Battelle Memorial Institute
    Inventors: Brian L. Burback, Jessica Catherine Bright, Jerry D. Johnson
  • Publication number: 20200171010
    Abstract: Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.
    Type: Application
    Filed: November 26, 2019
    Publication date: June 4, 2020
    Inventors: Brian L. Burback, Jessica Catherine Bright, Jerry D. Johnson
  • Publication number: 20180214433
    Abstract: Disclosed herein are methods of reducing muscle contraction in a diaphragm or peripheral muscle(s) of a patient sufficient to permit a surgical procedure. The methods may comprise the step of administering an oxime or pharmaceutically acceptable salt thereof to a subject in need thereof in an amount sufficient to achieve said reduced muscle contraction/neuromuscular blockade. Kits and articles of manufacture comprising a container having a label and a composition are also disclosed.
    Type: Application
    Filed: February 1, 2018
    Publication date: August 2, 2018
    Inventors: Brian L. Burback, Jessica Catherine Bright, Jerry D. Johnson